Wheeler Bio

Wheeler Bio is a biomanufacturing company aimed at accelerating the translation of therapeutic innovations into clinical impact. By integrating in parallel with preclinical discovery, Wheeler is leveraging its rapid, high-quality biomanufacturing and Portable CMC™ platform to democratize access to integrated discovery-to-IND programs. The company is initially focused on antibody therapies and is collaborating with Alloy Therapeutics to provide emerging biopharmaceutical companies with faster and more predictable clinical pathways by avoiding critical gaps between discovery and early development.